Resolution: standard / high
Figure 3.
Relative risks for FDA MR with appetite suppressants.
Loke et al. BMC Clinical Pharmacology 2002 2:6 doi:10.1186/1472-6904-2-6
Download authors' original image
|
Resolution: standard / high Figure 3.
Relative risks for FDA MR with appetite suppressants.
Loke et al. BMC Clinical Pharmacology 2002 2:6 doi:10.1186/1472-6904-2-6 |